Skip to content

John Pinion

Chief Operating Officer at Amlogenyx.

Earliest Form D on file: Jul 2026

Filed Jul 9, 2026

Amlogenyx

Gene therapy that clears amyloid in Alzheimer's disease

Biotech, Novato CA

Signed as Chief Operating Officer

$10M

sold of $20M offered

Form D

Network

At Amlogenyx

5 people